Procter & Gamble to form consumer-health venture with Teva
Teva Pharmaceutical Industries Ltd. (TEVA) and Procter & Gamble Co. (PG) agreed to combine their consumer-health businesses outside North America in a joint venture that aims to capture more of the $200 billion market for over-the-counter medicines. Read the full story here.
Teva Pharmaceutical Industries Ltd. (TEVA) and Procter & Gamble Co. (PG) agreed to combine their consumer-health businesses outside North America in a joint venture that aims to capture more of the $200 billion market for over-the-counter medicines.
Read the full story here.
Author
